EX-4.2



 Exhibit 4.2 

EXECUTION VERSION 
 ACACIA
COMMUNICATIONS, INC. 
 AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

April 17, 2013 







 TABLE OF CONTENTS 

 

									
	 	 	 	  	 	  	Page	 
	1.	 	Definitions	  	 	1	  
			
	2.	 	Registration Rights	  	 	5	  
				
		 	2.1	  	Demand Registration	  	 	5	  
		 	2.2	  	Company Registration	  	 	7	  
		 	2.3	  	Underwriting Requirements	  	 	7	  
		 	2.4	  	Obligations of the Company	  	 	8	  
		 	2.5	  	Furnish Information	  	 	10	  
		 	2.6	  	Expenses of Registration	  	 	10	  
		 	2.7	  	Delay of Registration	  	 	10	  
		 	2.8	  	Indemnification	  	 	10	  
		 	2.9	  	Reports Under Exchange Act	  	 	12	  
		 	2.10	  	Limitations on Subsequent Registration Rights	  	 	13	  
		 	2.11	  	“Market Stand-off” Agreement	  	 	13	  
		 	2.12	  	Restrictions on Transfer	  	 	14	  
			
	3.	 	Information and Observer Rights	  	 	15	  
				
		 	3.1	  	Delivery of Financial Statements	  	 	15	  
		 	3.2	  	Inspection	  	 	17	  
		 	3.3	  	Observer Rights	  	 	17	  
		 	3.4	  	Termination of Information and Observer Rights	  	 	18	  
		 	3.5	  	Confidentiality	  	 	18	  
			
	4.	 	Rights to Future Stock Issuances	  	 	18	  
				
		 	4.1	  	Right of First Offer	  	 	18	  
		 	4.2	  	Termination	  	 	19	  
			
	5.	 	Additional Covenants	  	 	19	  
				
		 	5.1	  	Insurance	  	 	19	  
		 	5.2	  	Employee Agreements	  	 	20	  
		 	5.3	  	Employee Stock	  	 	20	  
		 	5.4	  	Qualified Small Business Stock	  	 	20	  
		 	5.5	  	Matters Requiring Investor Director Approval	  	 	21	  
		 	5.6	  	Board Matters	  	 	22	  
		 	5.7	  	Directors’ Liability and Indemnification	  	 	22	  
		 	5.8	  	Indemnification of Fund Directors	  	 	22	  
		 	5.9	  	Successor Indemnification	  	 	23	  
		 	5.10	  	Termination of Covenants	  	 	23	  
			
	6.	 	Miscellaneous	  	 	23	  
				
		 	6.1	  	Successors and Assigns	  	 	23	  
		 	6.2	  	Governing Law	  	 	24	  
		 	6.3	  	Counterparts; Facsimile	  	 	24	  


  
 i 









									
		 	6.4	  	Titles and Subtitles	  	 	24	  
		 	6.5	  	Notices	  	 	24	  
		 	6.6	  	Amendments and Waivers	  	 	25	  
		 	6.7	  	Severability	  	 	25	  
		 	6.8	  	Aggregation of Stock	  	 	25	  
		 	6.9	  	Entire Agreement	  	 	26	  
		 	6.10	  	Dispute Resolution	  	 	26	  
		 	6.11	  	WAIVER OF JURY TRIAL	  	 	26	  
		 	6.12	  	Costs of Enforcement	  	 	26	  
		 	6.13	  	Delays or Omissions	  	 	26	  
		 	6.14	  	Acknowledgment	  	 	27	  
		 	6.15	  	Additional Investors	  	 	27	  
		 	6.16	  	Termination of Prior Agreement	  	 	27	  

 Schedule A    -        Schedule of Investors 

  
 ii 








 AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 17th day of
April, 2013 by and among Acacia Communications, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto (each of which individually is referred to in this Agreement as an
“Investor” and collectively as the “Investors”). 
 RECITALS 

WHEREAS, the Company and certain of the Investors have previously entered into an Amended and Restated Investors’ Rights
Agreement, dated as of March 5, 2013 (the “Prior Agreement”), which provides each such Investor with the right to, among other things, cause the Company to register shares of Common Stock issuable to the Investors, receive
certain information from the Company, and participate in future equity offerings by the Company; 
 WHEREAS, concurrently with the
execution of this Agreement, the Company and certain of the Investors, including the Summit Investors, are entering into a Series D Preferred Stock Purchase Agreement of even date herewith (the “Series D Purchase Agreement”); and

 WHEREAS, the Investors desire to amend and restate the Prior Agreement to add the Summit Investors as parties to this Agreement
and to accept the rights and obligations created pursuant hereto in lieu of the rights created under the Prior Agreement; 
 NOW,
THEREFORE, the parties hereby agree as follows: 
 1. Definitions. For purposes of this Agreement: 

1.1 “Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is
controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more
general partners or managing members of, or shares the same management company with, such Person. 
 1.2 “Certificate of
Incorporation” means the Company’s Fourth Amended and Restated Certificate of Incorporation, as amended. 
 1.3
“Common Stock” means shares of the Company’s common stock, par value $0.0001 per share. 
 1.4
“Damages” means any loss, damage, or liability (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, or liability (or
any action in respect thereof) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus or final
prospectus contained therein or any amendments or supplements thereto; 







 
(ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or (iii) any violation
or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any state
securities law. 
 1.5 “Derivative Securities” means any securities or rights convertible into, or exercisable or
exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants. 
 1.6 “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 
 1.7
“Excluded Registration” means (i) a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to
an SEC Rule 145 transaction; (iii) a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or
(iv) a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered. 

1.8 “Form S-1” means such form under the Securities Act as in effect on the date
hereof or any successor registration form under the Securities Act subsequently adopted by the SEC. 
 1.9 “Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial
information by reference to other documents filed by the Company with the SEC. 
 1.10 “GAAP” means generally accepted
accounting principles in the United States. 
 1.11 “Holder” means any holder of Registrable Securities who is a party to
this Agreement and shall include, for purposes of Section 2 of the Agreement, MassDevelopment (as defined below) and, solely for purposes of Sections 1, 2.1 through 2.11, 2.13 and 6 hereof (the “Applicable Sections”), SVB (as
defined below). 
 1.12 “Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent,
spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, life partners and others covered under any applicable domestic relations statute of a natural person
referred to herein. 
 1.13 “Initiating Holders” means, collectively, Holders who properly initiate a registration request
under this Agreement. 

  
 2 








 1.14 “Investor” has the meaning ascribed to it in the introductory paragraph
hereto and shall include, for purposes of Section 2 of the Agreement, MassDevelopment and, solely for purposes of the Applicable Sections, SVB. 

1.15 “IPO” means the Company’s first underwritten public offering of its Common Stock under the Securities Act. 

1.16 “Key Employee” means any executive-level employee (including division director and vice president-level positions) as
well as any employee or consultant who either alone or in concert with others has made a material technical contribution to any Company Intellectual Property. 

1.17 “Major Investor” means any Investor that, individually or together with such Investor’s Affiliates, holds at least
1,000,000 shares of Registrable Securities (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof) and OFS FITEL, LLC, or its Affiliates, successors or permitted
assigns (individually and collectively “OFS”), for so long as OFS continues to hold at least 500,000 shares of Preferred Stock or Common Stock or other securities (as adjusted for any stock split, stock dividend, combination, or
other recapitalization or reclassification effected after the date hereof and regardless whether or not issued or issuable upon conversion of the Preferred Stock). 

1.18 “MassDevelopment” means Massachusetts Development Finance Agency. 

1.19 “New Securities” means, collectively, equity securities of the Company, whether or not currently authorized, as well as
rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such equity securities. 

1.20 “Person” means any individual, corporation, partnership, trust, limited liability company, association or other entity.

 1.21 “Preferred Directors” means collectively the Series A Director, the Series B Director and the Series D Director.

 1.22 “Preferred Stock” means the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock
and the Series D Preferred Stock, provided, however, that the shares issued and issuable upon exercise or conversion of that certain Warrant to Purchase Stock issued by the Company to SVB dated June 9, 2011 (the “SVB
Warrant”) shall be deemed “Preferred Stock” solely for purposes of the Applicable Sections. 
 1.23 “Registrable
Securities” means (i) the Common Stock issuable or issued upon conversion of the Preferred Stock, excluding any Common Stock issued upon conversion of the Preferred Stock pursuant to the “Special Mandatory Conversion”
provisions of the Company’s Certificate of Incorporation; (ii) any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company, acquired by any of the
Investors after the date hereof; (iii) any Common Stock issued 

  
 3 








 
as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement
of, the shares referenced in clauses (i) and (ii) above, (iv) for purposes of Section 2 of this Agreement, all shares of Common Stock of the Company now or hereafter held by MassDevelopment, including, without limitation,
the shares of Common Stock issued or issuable upon conversion of the Preferred Stock issued or issuable upon exercise of the warrant to purchase Preferred Stock held by MassDevelopment, and (v) solely for purposes of the Applicable Sections,
all shares of Common Stock issued and issuable upon conversion of the shares of Preferred Stock issued and issuable upon exercise or conversion of the SVB Warrant (and all shares of Common Stock issued and issuable upon exercise or conversion of the
SVB Warrant at all times, if any, when the Class (as defined in the SVB Warrant), shall be Common Stock); provided, however, that any such shares referenced in clauses (iv) and (v) above shall not be deemed “Registrable
Shares” for the purposes of participating as an Initiating Holder in the making of a demand for a Form S-1 registration statement pursuant to Section 2.1(a); excluding in all cases, however, any Registrable Securities sold by a
Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant to Section 6.1. For purposes of this Agreement, a Person shall be deemed to be a holder of Registrable Securities, and the Registrable
Securities shall be deemed to be in existence, whenever such Person has the right to acquire, directly or indirectly, such Registrable Securities (upon conversion or exercise in connection with a transfer of securities or otherwise, but disregarding
any restrictions or limitations upon the exercise of such right), whether or not such acquisition has actually been effected, and such Person shall be entitled to exercise the rights of a Holder hereunder. 

1.24 “Restricted Securities” means the securities of the Company required to bear the legend set forth in
Section 2.12(b) hereof. 
 1.25 “SEC” means the Securities and Exchange Commission. 

1.26 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act. 

1.27 “SEC Rule 144(b)(1)(i)” means Rule 144(b)(1)(i) promulgated by the SEC under the Securities Act. 

1.28 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act. 

1.29 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 1.30 “Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable to
the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of any Selling Holder Counsel borne and paid by the Company as provided in Section 2.6. 

1.31 “Series A Director” means any director of the Company that the holders of record of the Series A Preferred Stock
are entitled to elect pursuant to the Company’s Certificate of Incorporation. 

  
 4 








 1.32 “Series B Director” means any director of the Company that the holders of
record of the Series B Preferred Stock are entitled to elect pursuant to the Company’s Certificate of Incorporation. 
 1.33
“Series D Director” means any director of the Company that the holders of record of the Series D Preferred Stock are entitled to elect pursuant to the Company’s Certificate of Incorporation. 

1.34 “Series A Preferred Stock” means shares of the Company’s Series A Preferred Stock, par value $0.0001 per share.

 1.35 “Series B Preferred Stock” means shares of the Company’s Series B Preferred Stock, par value $0.0001 per
share. 
 1.36 “Series C Preferred Stock” means shares of the Company’s Series C Preferred Stock, par value $0.0001
per share. 
 1.37 “Series D Preferred Stock” means shares of the Company’s Series D Preferred Stock, par value
$0.0001 per share. 
 1.38 “Summit Investors” means, collectively, Summit Partners Venture Capital Fund III-A, L.P., Summit
Partners Venture Capital Fund III-B, L.P., Summit Investors I, LLC, Summit Investors I (UK), L.P., any of their respective partners, members or Affiliates and any of their respective transferees or Affiliates that are Investors. 

1.39 “SVB” means Silicon Valley Bank, its successors and assigns. 

2. Registration Rights. The Company covenants and agrees as follows: 

2.1 Demand Registration. 

(a) Form S-1 Demand. If at any time after the earlier of (i) four (4) years after the date of this Agreement
and (ii) six (6) months after the effective date of the registration statement for the IPO, the Company receives a request from Holders of thirty percent (30%) of the Registrable Securities then outstanding that the Company file a
Form S-1 registration statement with respect to all or any portion of the Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses, of at least $7.5 million, then the Company shall
(i) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”) to all Holders other than the Initiating Holders; and (ii) as soon as practicable, and in any event within sixty
(60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any
additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each
case, subject to the limitations of Section 2.1(c) and Section 2.3. 

  
 5 








 (b) Form S-3 Demand. If at any time when it is eligible to use a Form S-3
registration statement, the Company receives a request from Holders of at least ten percent (10%) of the Registrable Securities then outstanding that the Company file a Form S-3 registration statement with respect to outstanding Registrable
Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses, of at least $5 million, then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all
Holders other than the Initiating Holders; and (ii) as soon as practicable, and in any event within forty-five (45) days after the date such request is given by the Initiating Holders, file a Form S-3 registration statement under the
Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is
given, and in each case, subject to the limitations of Section 2.1(c) and Section 2.3. After the IPO, the Company shall use its reasonable best efforts to become and remain eligible for registration on Form S-3. 

(c) Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this
Section 2.1 a certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Company’s Board of Directors it would be materially detrimental to the Company and its stockholders for
such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially interfere with a significant
acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or
(iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with respect to filing or
effectiveness thereof shall be tolled correspondingly, for a period of not more than sixty (60) days after the request of the Initiating Holders is given; provided, however, that the Company may not invoke this right more than
once in any twelve (12) month period; and provided further that the Company shall not register any securities for its own account or that of any other stockholder during such sixty (60) day period other than an Excluded
Registration. 
 (d) The Company shall not be obligated to effect any registration pursuant to Section 2.1(a) (i) during
the period beginning on the date of filing of, and ending on a date that is one hundred eighty (180) days after the effective date of, a Company-initiated registration, provided, that the Company is actively employing in good faith
commercially reasonable efforts to cause such registration statement to become effective; (ii) after the Company has effected two registrations pursuant to Section 2.1(a); or (iii) if the Initiating Holders propose to dispose
of shares of Registrable Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.1(b). The Company shall not be obligated to effect any registration pursuant to
Section 2.1(b) (i) during the period beginning on the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration, provided, that the Company is actively
employing in good faith commercially reasonable efforts to cause such registration statement to become effective; or (ii) if the Company has effected two registrations pursuant to Section 2.1(b) within the twelve (12) month
period immediately preceding the date of such request. 

  
 6 








 
Without in any way limiting the generality of Section 2.3(c), a registration shall not be counted as “effected” for purposes of this Section 2.1(d) until such
time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw their request for such registration, elect not to pay the registration expenses therefor, and forfeit their right to one
demand registration statement pursuant to Section 2.6, in which case such withdrawn registration statement shall be counted as “effected” for purposes of this Section 2.1(d). 

2.2 Company Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company for
stockholders other than the Holders) any of its Common Stock under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give
each Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the provisions of Section 2.3, cause to be registered
all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.2 before the
effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance
with Section 2.6. 
 2.3 Underwriting Requirements. 

(a) If, pursuant to Section 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by their request
by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Section 2.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will be selected by the
Initiating Holders, subject only to the reasonable approval of the Company. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s participation
in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. Notwithstanding any other provision of this Section 2.3, if the managing underwriter(s) advise(s) the
Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant
hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of
Registrable Securities owned by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however, that the number of Registrable Securities held by the Holders to be included in such
underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of
shares allocated to any Holder to the nearest 100 shares. 
 (b) In connection with any offering involving an underwriting of shares of the
Company’s capital stock pursuant to Section 2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting only in such quantity


  
 7 








 
as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities,
requested by stockholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the
Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters in their sole discretion determine will not jeopardize the success of the offering. If the
underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in
proportion (as nearly as practicable to) the number of Registrable Securities owned by each selling Holder or in such other proportions as shall mutually be agreed to by all such selling Holders. To facilitate the allocation of shares in accordance
with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 100 shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in
the offering be reduced unless all other securities (other than securities to be sold by the Company) are first entirely excluded from the offering, or (ii) the number of Registrable Securities included in the offering be reduced below thirty
percent (30%) of the total number of securities included in such offering, unless such offering is the IPO, in which case the selling Holders may be excluded further if the underwriters make the determination described above and no other
stockholder’s securities are included in such offering. For purposes of the provision in this Section 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the
partners, members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any
of the foregoing Persons, shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons
included in such “selling Holder,” as defined in this sentence. 
 (c) For purposes of Section 2.1, a registration
shall not be counted as “effected” if, as a result of an exercise of the underwriter’s cutback provisions in Section 2.3(a), fewer than one hundred percent (100%) of the total number of Registrable Securities that
Holders have requested to be included in such registration statement are actually included. 
 2.4 Obligations of the Company.
Whenever required under this Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred
twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such one hundred twenty (120) day period shall be extended for a period
of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any securities included in such registration, and (ii) in the case of any registration of


  
 8 








 
Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such one hundred twenty (120) day period
shall be extended for up to 180 days, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; 

(b) prepare and file with the SEC such amendments and supplements to such registration statement, and the prospectus used in connection with
such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement; 

(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any
such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the underwriter(s) of such offering; 
 (f) use its commercially reasonable efforts to cause all such Registrable
Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 

(g) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration; 
 (h) promptly make available
for inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling
Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any
such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(i) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been
declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 

  
 9 








 (j) after such registration statement becomes effective, notify each selling Holder of any
request by the SEC that the Company amend or supplement such registration statement or prospectus. 
 2.5 Furnish Information. It
shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such
information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities. 

2.6 Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or
qualifications pursuant to Section 2, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of custodians, underwriters, counsel and other Persons retained by the Company;
and the reasonable fees and disbursements of one counsel for the selling Holders and the reasonable fees and disbursements of each additional counsel retained by any Holder of Registrable Securities for the purpose of rendering a legal opinion on
behalf of such Holder in connection with any underwritten registration (each, “Selling Holder Counsel”), whether or not such registration shall have become effective shall be borne and paid by the Company; provided,
however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 if the registration request is subsequently withdrawn at the request of the Holders of a majority
of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders of a
majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Section 2.1(a) or Section 2.1(b), as the case may be; provided further that if, at the time of such withdrawal, the
Holders shall have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness after learning of
such information then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one registration pursuant to Section 2.1(a) or Section 2.1(b). All Selling Expenses relating to
Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on their behalf. 

2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. If any Registrable Securities are included in a registration statement under this Section 2: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, members, officers,
directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any 

  
 10 








 
underwriter (as defined in the Securities Act) for each such Holder; and each Person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act,
against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or
proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.8(a) shall not apply to amounts paid in settlement of any such claim or
proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or
omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person, or other aforementioned Person expressly for use in connection with such registration. 

(b) To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of
its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the
Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based
upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with such registration; and each such selling Holder will pay to the Company
and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided,
however, that the indemnity agreement contained in this Section 2.8(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent
shall not be unreasonably withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity or contribution under Sections 2.8(b) and 2.8(d) exceed the proceeds from the
offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder. 

(c) Promptly after receipt by an indemnified party under this Section 2.8 of notice of the commencement of any action (including any
governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.8, give the indemnifying party
notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to which notice has been given,
and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual
or potential differing interests between such indemnified party and any other party represented by such 

  
 11 








 
counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability
to the indemnified party under this Section 2.8, to the extent that such failure materially prejudices the indemnifying party’s ability to defend such action. The failure to give notice to the indemnifying party will not relieve it
of any liability that it may have to any indemnified party otherwise than under this Section 2.8. 
 (d) To provide for just
and equitable contribution to joint liability under the Securities Act in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Section 2.8 but it
is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case,
notwithstanding the fact that this Section 2.8 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this
Section 2.8, then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate
to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any
other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the
omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent
such statement or omission; provided, however, that, in any such case, (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such
Holder pursuant to such registration statement, and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of
such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Section 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to
Section 2.8(b), exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. 

(e) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the
obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall survive the termination of this
Agreement. 
 2.9 Reports Under Exchange Act. With a view to making available to the Holders the benefits of SEC Rule 144 and any
other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company shall: 

(a) make and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all times
after the effective date of the registration statement filed by the Company for the IPO; 

  
 12 








 (b) use commercially reasonable efforts to file with the SEC in a timely manner all reports and
other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and 

(c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a
written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the IPO), the Securities
Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any
time after the Company so qualifies); (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company; and (iii) such other information as may be reasonably requested in
availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form
S-3 (at any time after the Company so qualifies to use such form). 
 2.10 Limitations on
Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any
holder or prospective holder of any securities of the Company that would allow such holder or prospective holder (i) to include such securities in any registration unless, under the terms of such agreement, such holder or prospective holder may
include such securities in any such registration only to the extent that the inclusion of such securities will not reduce the number of the Registrable Securities of the Holders that are included or (ii) to initiate a demand for registration of
any securities held by such holder or prospective holder. 
 2.11 “Market Stand-off”
Agreement. Each Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company’s IPO and ending on the date
specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days or, if required by such underwriter, such longer period of time as is necessary to enable such underwriter to issue a research report
or make a public appearance that relates to an earnings release or announcement by the Company within fifteen (15) days prior to or after the date that is one hundred eighty (180) days after the effective date of the registration statement
relating to such offering, but in any event not to exceed two hundred ten (210) days following the effective date of the registration statement relating to such offering (i) lend; offer; pledge; sell; contract to sell; sell any option or
contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable
or exchangeable (directly or indirectly) for Common Stock held immediately before the effective 

  
 13 








 
date of the registration statement for such offering or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of this
Section 2.11, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall be applicable to the Holders only if all officers and directors who hold stock are subject to similar restrictions
and the Company uses commercially reasonable efforts to obtain a similar agreement from all stockholders individually owning more than one percent (1%) of the Company’s outstanding Common Stock (after giving effect to conversion into
Common Stock of all outstanding shares of Preferred Stock). The underwriters in connection with such registration are intended third-party beneficiaries of this Section 2.11 and shall have the
right, power, and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are
consistent with this Section 2.11 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata
to all Holders subject to such agreements, based on the number of shares subject to such agreements. 
 2.12 Restrictions on
Transfer. 
 (a) The Preferred Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and the
Company shall not recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure
compliance with the provisions of the Securities Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities
subject to the provisions and upon the conditions specified in this Agreement. 
 (b) Each certificate or instrument representing
(i) the Preferred Stock, (ii) the Registrable Securities, and (iii) any other securities issued in respect of the securities referenced in clauses (i) and (ii), upon any stock split, stock dividend, recapitalization, merger,
consolidation, or similar event, shall (unless otherwise permitted by the provisions of Section 2.12(c)) be stamped or otherwise imprinted with a legend substantially in the following form: 

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES
MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER,
A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 

  
 14 








 The Holders consent to the Company making a notation in its records and giving instructions to any transfer agent
of the Restricted Securities in order to implement the restrictions on transfer set forth in this Section 2.12. 
 (c) The
holder of each certificate representing Restricted Securities, by acceptance thereof, agrees to comply in all respects with the provisions of this Section 2. Before any proposed sale, pledge, or transfer of any Restricted Securities,
unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the Holder thereof shall give notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each such
notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if reasonably requested by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of
legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the Company, to the effect that the proposed transaction may be effected without registration under the Securities Act; (ii) a
“no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities without registration will not result in a recommendation by the staff of the SEC that action be taken with respect
thereto; or (iii) any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or transfer of the Restricted Securities may be effected without registration under the Securities Act,
whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in accordance with the terms of the notice given by the Holder to the Company. The Company will not require such a legal
opinion or “no action” letter (x) in any transaction in compliance with SEC Rule 144 or (y) in any transaction in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration;
provided that each transferee agrees in writing to be subject to the terms of this Section 2.12. Each certificate or instrument evidencing the Restricted Securities transferred as above provided shall bear, except if such transfer
is made pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Section 2.12(b), except that such certificate shall not bear such restrictive legend if, in the opinion of counsel for such Holder and the Company,
such legend is not required in order to establish compliance with any provisions of the Securities Act. 
 3. Information and Observer
Rights. 
 3.1 Delivery of Financial Statements. The Company shall deliver to each Major Investor: 

(a) as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the Company, (i) a
balance sheet as of the end of such year, and a comparison between (x) the actual amounts as of and for such fiscal year and (y) the comparable amounts for the prior year as included in the Budget (as defined in Section 3.1(d))
for such year, (ii) statements of income and of cash flows for such year, and (iii) a statement of stockholders’ equity as of the end of such year, all such financial statements audited and certified by independent public accountants
of nationally recognized standing selected by the Company; 

  
 15 








 (b) as soon as practicable, but in any event within
forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, unaudited statements of income and of cash flows for such fiscal quarter, and an
unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and
(ii) not contain all notes thereto that may be required in accordance with GAAP); 
 (c) as soon as practicable, but in any event
within forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock and securities convertible into or
exercisable for shares of capital stock outstanding at the end of the period, the Common Stock issuable upon conversion or exercise of any outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price
applicable thereto, and the number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to permit the Major Investors to calculate their respective percentage equity
ownership in the Company, and certified by the chief financial officer or chief executive officer of the Company as being true, complete, and correct; 

(d) as soon as practicable, but in any event within thirty (30) days of the end of each month, an unaudited income statement and
statement of cash flows for such month, and an unaudited balance sheet as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and
(ii) not contain all notes thereto that may be required in accordance with GAAP); 
 (e) as soon as practicable, but in any event
thirty (30) days before the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the “Budget”), approved by the Board of Directors and prepared on a monthly basis, including balance
sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company; 

(f) with respect to the financial statements called for in Section 3.1(a), and Section 3.1(b), an instrument executed
by the chief financial officer or chief executive officer of the Company certifying that such financial statements were prepared in accordance with GAAP consistently applied with prior practice for earlier periods (except as otherwise set forth in
Section 3.1(b)) and fairly present the financial condition of the Company and its results of operation for the periods specified therein; and 

(g) such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major
Investor may from time to time reasonably request; provided, however, that the Company shall not be obligated under this Section 3.1 to provide information (i) that the Company reasonably determines in good faith to be
a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the Company) or (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company
and its counsel. 

  
 16 








 If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company,
then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

3.2 Inspection. The Company shall permit each Major Investor and its accountants, counsel and other representatives, at such Major
Investor’s expense, to visit and inspect the Company’s properties; examine its books of account and records; and discuss the Company’s affairs, finances, and accounts with its officers, during normal business hours of the Company as
may be reasonably requested by the Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 3.2 to provide access to any information that it reasonably and in good faith considers
to be a trade secret or confidential information (unless such trade secret or confidential information is covered by an enforceable confidentiality agreement, in a reasonable and customary form mutually acceptable to the Company and the applicable
Major Investor) or the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. 
 3.3
Observer Rights. 
 (a) For so long as OFS remains a Major Investor, the Company shall invite a representative of OFS to attend all
meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same
manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further,
that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could (i) result in disclosure of trade secrets
(unless covered by an enforceable confidentiality agreement, in a reasonable and customary form mutually acceptable to the Company and OFS), (ii) adversely affect the attorney-client privilege between the Company and its counsel,
(iii) result in a conflict of interest, or (iv) if such Investor or its representative is a competitor of the Company (as reasonably determined by the Board of Directors). 

(b) For so long as Egan Managed Capital remains a Major Investor, the Company shall invite a representative of Egan Managed Capital to attend
all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the
same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust with respect to all information so provided; and provided further, that the Company reserves the
right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could (i) result in disclosure of trade secrets (unless covered by an
enforceable confidentiality agreement, in a reasonable and customary form mutually acceptable to the Company and Egan Managed Capital), (ii) adversely affect the attorney-client privilege between the Company and its counsel, or
(iii) result in a conflict of interest. 

  
 17 








 3.4 Termination of Information and Observer Rights. The covenants set forth in
Section 3.1, Section 3.2, and Section 3.3 shall not be effective during any period that the Company is subject to and in compliance with the periodic reporting requirements of Section 12(g) or 15(d) of the
Exchange Act. 
 3.5 Confidentiality. Each Investor agrees that such Investor will keep confidential and will not disclose any
confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file a registration statement), unless such confidential information (a) is known or becomes known
to the public in general (other than as a result of a breach of this Section 3.5 by such Investor), (b) is or has been independently developed or conceived by the Investor without use of the Company’s confidential information,
or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company; provided, however, that an Investor may disclose
confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective
purchaser of any Registrable Securities from such Investor, provided such prospective purchaser is not a competitor of the Company and such prospective purchaser agrees to be bound by the provisions of this Section 3.5;
(iii) to any existing or prospective Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is
confidential and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable steps
to minimize the extent of any such required disclosure. 
 4. Rights to Future Stock Issuances. 

4.1 Right of First Offer. Subject to the terms and conditions of this Section 4.1 and applicable securities laws, if the
Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted to it among itself and its
Affiliates in such proportions as it deems appropriate. 
 (a) The Company shall give notice (the “Offer Notice”) to each
Major Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such New Securities. 

(b) By notification to the Company within twenty (20) days after the Offer Notice is given, each Major Investor may elect to purchase or
otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities, which equals the proportion that the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or
exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held, by such Major Investor bears to the total Common Stock of the Company issued and held, or issuable (directly or indirectly) upon conversion and/or
exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held, by all the 

  
 18 








 
Major Investors. At the expiration of such twenty (20) day period, the Company shall promptly notify each Major Investor that elects to purchase or acquire all the shares available to it
(each, a “Fully Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten (10) day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving
notice to the Company, elect to purchase or acquire, in addition to the number of shares specified above, up to that portion of the New Securities for which Major Investors were entitled to subscribe but that were not subscribed for by the Major
Investors which is equal to the proportion that the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of Preferred Stock and any other Derivative Securities then held, by such Fully
Exercising Investor bears to the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of Preferred Stock and any other Derivative Securities then held, by all Fully Exercising Investors
who wish to purchase such unsubscribed shares. The closing of any sale pursuant to this Section 4.1(b) shall occur within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New
Securities pursuant to Section 4.1(c). 
 (c) If all New Securities referred to in the Offer Notice are not elected to be
purchased or acquired as provided in Section 4.1(b), the Company may, during the ninety (90) day period following the expiration of the periods provided in Section 4.1(b), offer and sell the remaining
unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of
the New Securities within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless
first reoffered to the Major Investors in accordance with this Section 4.1. 
 (d) The right of first offer in this
Section 4.1 shall not be applicable to (i) Exempted Securities (as defined in the Company’s Certificate of Incorporation); (ii) shares of Common Stock issued in the IPO; and (iii) the issuance of shares of
Series D Preferred Stock pursuant to the Series D Purchase Agreement. 
 4.2 Termination. The covenants set forth in
Section 4.1 shall terminate and be of no further force or effect upon the earlier of (i) the consummation of the Company’s first underwritten public offering of its Common Stock in which all of the Company’s Preferred
Stock is converted into Common Stock, or (ii) the liquidation, dissolution and winding up of the Company or the consummation of a sale, lease, license, transfer, conveyance or other disposition to an independent third party, directly or
indirectly, in one transaction or a series of related transactions (including by way of merger, consolidation, recapitalization, reorganization or sale of securities) of all or substantially all of the shares of capital stock of the Company or all
or substantially all of the assets of the Company and its subsidiaries, taken as a whole. 
 5. Additional Covenants. 

5.1 Insurance. The Company shall use its commercially reasonable efforts to obtain within one hundred twenty (120) days following
the date hereof or maintain, from 

  
 19 








 
financially sound and reputable insurers, (a) Directors and Officers liability insurance; (b) term “key-person” insurance on
Raj Shanmugaraj, Benny Mikkelsen, Christian Rasmussen and Mehrdad Givehchi and (c) property and general liability insurance, each in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially
reasonable efforts to cause such insurance policies to be maintained until such time as the Board of Directors determines that such insurance should be discontinued. The key-person policy shall name the
Company as loss payee, and neither policy shall be cancelable by the Company without prior approval by the Board of Directors, including at least two (2) of the Preferred Directors. 

5.2 Employee Agreements. The Company will cause (i) each person now or hereafter employed by it or by any subsidiary (or engaged
by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets and/or with a role in developing, modifying or implementing Company Intellectual Property (as defined in the Series
D Purchase Agreement) to enter into a nondisclosure and proprietary rights assignment agreement in a form reasonably acceptable to the Investors and (ii) each Key Employee to enter into a one (1) year noncompetition and nonsolicitation
agreement, in a form reasonably acceptable to the Investors. In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement
between the Company and any employee, without the prior approval by the Board of Directors, including at least two (2) of the Preferred Directors. 

5.3 Employee Stock. Unless otherwise approved by the Board of Directors, including at least two (2) of the Preferred Directors,
all future employees and consultants of the Company who purchase, receive options to purchase, or receive awards of shares of the Company’s capital stock after the date hereof shall be required to execute restricted stock or option agreements,
as applicable, providing for (i) vesting of shares over a five (5) year period, with the first twenty percent (20%) of such shares vesting following twelve (12) months of continued employment or service, and the remaining shares
vesting in equal monthly installments over the following forty-eight (48) months, such vesting to be accelerated by six (6) months in the case of an acquisition of the Company, and (ii) a market stand-off provision substantially
similar to that in Section 2.11. In addition, unless otherwise approved by the Board of Directors, including at least two (2) of the Preferred Directors, the Company shall retain a “right of first refusal” on employee
transfers until the Company’s IPO and shall have the right to repurchase unvested shares at cost upon termination of employment of a holder of restricted stock. In the event of any assignment, designation or delegation of any “right of
first refusal” by the Company, the Company shall offer such right to the Investors pro rata based on the Investor’s fully-diluted ownership of Common Stock (assuming full conversion of all Preferred Stock). 

5.4 Qualified Small Business Stock. The Company shall use commercially reasonable efforts to cause the shares of Preferred Stock issued
pursuant to the Series A Purchase Agreement, Series B Purchase Agreement, Series C Purchase Agreement and the Series D Purchase Agreement, as well as any shares into which such shares are converted, within the meaning of Section 1202(f) of the
Internal Revenue Code (the “Code”), to constitute “qualified small business stock” as defined in Section 1202(c) of the Code; provided, however, that such requirement shall not be applicable if the Board
of Directors of the Company determines, in its good-faith business judgment, that such qualification is inconsistent with the best interests of the 

  
 20 








 
Company. The Company shall submit to its stockholders (including the Investors) and to the Internal Revenue Service any reports that may be required under Section 1202(d)(1)(C) of the Code
and the regulations promulgated thereunder. In addition, within twenty (20) business days after any Investor’s written request therefor, the Company shall, at its option, either (i) deliver to such Investor a written statement
indicating whether (and what portion of) such Investor’s interest in the Company constitutes “qualified small business stock” as defined in Section 1202(c) of the Code or (ii) deliver to such Investor such factual
information in the Company’s possession as is reasonably necessary to enable such Investor to determine whether (and what portion of) such Investor’s interest in the Company constitutes “qualified small business stock” as defined
in Section 1202(c) of the Code. 
 5.5 Matters Requiring Investor Director Approval. So long as at least one million
(1,000,000) shares of Series A Preferred Stock, at least one million (1,000,000) shares of Series B Preferred Stock and at least one million (1,000,000) shares of Series D Preferred Stock (each as adjusted for any stock split,
stock dividend, combination, or other recapitalization or reclassification effected after the date hereof) remain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of
Directors, which approval must include the affirmative vote of the Series A Director, the Series B Director and the Series D Director: 

(a) make, or permit any subsidiary to make, any loan or advance to, or own any stock or other securities of, any subsidiary or other
corporation, partnership, or other entity unless it is wholly owned by the Company; 
 (b) make, or permit any subsidiary to make, any loan
or advance to any Person, including, without limitation, any employee or director of the Company or any subsidiary, except advances and similar expenditures in the ordinary course of business or under the terms of an employee stock or option plan
approved by the Board of Directors; 
 (c) guarantee, directly or indirectly, or permit any subsidiary to guarantee, directly or
indirectly, any indebtedness except for trade accounts of the Company or any subsidiary arising in the ordinary course of business; 
 (d)
make any investment other than investments in prime commercial paper, money market funds, certificates of deposit in any United States bank having a net worth in excess of one hundred million dollars ($100,000,000) or obligations issued or
guaranteed by the United States of America, in each case having a maturity not in excess of one (1) year; 
 (e) incur any aggregate
indebtedness in excess of $25,000 that is not already included in a budget approved by the Board of Directors, other than trade credit incurred in the ordinary course of business; 

(f) otherwise enter into or be a party to any transaction with any director, officer, employee, stockholder or Affiliate of the Company or
any individual related by blood, marriage or adoption to any such individual or any entity in which any such Person or individual owns any beneficial interest, except for transactions contemplated by this Agreement or the Series D Purchase
Agreement; 

  
 21 








 (g) hire, terminate, or change the compensation of the executive officers, including approving
any option grants or stock awards to executive officers; 
 (h) change the principal business of the Company, enter new lines of business,
or exit the current line of business; or 
 (i) sell, transfer, assign, license, pledge, or encumber material technology or intellectual
property, other than licenses granted in the ordinary course of business. 
 5.6 Board Matters. Unless otherwise determined by the
vote of a majority of the directors then in office, which majority shall include each of the Preferred Directors, the Board of Directors shall meet at least (4) times per year on a quarterly basis in accordance with an agreed-upon schedule. The
Company shall reimburse the directors for all reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors. The Company shall cause to be
established, as soon as practicable after such request, and will maintain, an audit and compensation committee, each of which shall include each of the Preferred Directors (unless otherwise waived in writing by the Person(s) entitled to designate
such Preferred Director). No member of management shall participate any compensation committee meeting or discussion that pertains to his or her own compensation. 

5.7 Directors’ Liability and Indemnification. For so long as any Preferred Director serves on the board of directors of the
Company, the Company shall use commercially reasonable efforts to ensure that its Certificate of Incorporation and bylaws, collectively, provide (a) for elimination of the liability of directors to the maximum extent permitted by law and
(b) for indemnification of directors for acts on behalf of the Company to the maximum extent permitted by law, and the Company shall maintain directors’ and officers’ liability insurance reasonably satisfactory to the Majority
Investors in effect at all times. 
 5.8 Indemnification of Fund Directors. The Company hereby acknowledges that one (1) or more
of the directors nominated to serve on the board of directors of the Company by the Investors (each a “Fund Director”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by one or more of
the Investors and certain of their affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to any Fund Director are primary and any
obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such Fund Director are secondary), (ii) that it shall be required to advance any expenses incurred by any Fund
Director and shall be liable for any expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any Fund Director to the extent required by the terms of the Certificate of Incorporation or bylaws of the Company (or any
agreement between the Company and such Fund Director), without regard to any rights such Fund Director may have against the Fund Indemnitors, and (iii) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all
claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof (except as to advances that are determined to be repayable to the Company). The Company further agrees that no advancement or
payment by the Fund Indemnitors on behalf of 

  
 22 








 
any Fund Director with respect to any claim for which such Fund Director has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a right of
contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Fund Director against the Company. The parties to this Agreement agree that any Fund Indemnitor that is not party to this
Agreement is an express third party beneficiary of the terms of this Section 5.8. 
 5.9 Successor Indemnification. If
the Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be
made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are
contained in the Company’s Bylaws, its Certificate of Incorporation, or elsewhere, as the case may be. 
 5.10 Termination of
Covenants. The covenants set forth in this Section 5, except for Sections 5.4 and 5.9, shall terminate and be of no further force or effect upon the earlier of (i) the consummation of the Company’s first
underwritten public offering of its Common Stock in which all of the Company’s Preferred Stock is converted into Common Stock, or (ii) the liquidation, dissolution and winding up of the Company or the consummation of a sale, lease,
license, transfer, conveyance or other disposition to an independent third party, directly or indirectly, in one transaction or a series of related transactions (including by way of merger, consolidation, recapitalization, reorganization or sale of
securities) of all or substantially all of the shares of capital stock of the Company or all or substantially all of the assets of the Company and its subsidiaries, taken as a whole. 

6. Miscellaneous. 
 6.1
Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s
Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder’s Immediate Family Members; or (iii) after such transfer, holds at least 50,000 shares of Registrable Securities (subject to appropriate
adjustment for stock splits, stock dividends, combinations, and other recapitalizations); provided, however, that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and
address of such transferee and the Registrable Securities with respect to which such rights are being transferred; and (y) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and
conditions of this Agreement, including the provisions of Section 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1) that is an Affiliate or
stockholder of a Holder; (2) who is a Holder’s Immediate Family Member; or (3) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of the
transferring Holder; provided further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking any action
under this Agreement. The terms and conditions of this 

  
 23 








 
Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer upon
any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein. 

6.2 Governing Law. This Agreement and any controversy arising out of or relating to this Agreement shall be governed by and construed
in accordance with the law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware. 

6.3 Counterparts; Facsimile. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile or electronic transmission in portable document (.pdf) or tagged image file (.tif) formats and any counterpart so delivered shall be
deemed to have been duly and validly delivered and be valid and effective for all purposes. 
 6.4 Titles and Subtitles. The titles
and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. 

6.5 Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given upon the earlier of actual receipt and: (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail or facsimile during the recipient’s normal business hours, and if not sent during
normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one (1) business day after the
business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery. All communications shall be sent to the respective parties at their addresses as set forth on Schedule A hereto, or to
the principal office of the Company and to the attention of the Chief Executive Officer, in the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written notice given in accordance with this
Section 6.5. 
 If notice is given to the Company, a copy shall also be sent to: 

Marc F. Dupré 
 Gunderson
Dettmer Stough Villeneuve Franklin & Hachigian, LLP 
 850 Winter Street 

Waltham, MA 02451 
 If notice is
given to Stockholders, a copy shall also be given to: 
 Philip P. Rossetti 

Latham & Watkins, LLP 

John Hancock Tower, 20th Floor 

200 Clarendon Street 
 Boston, MA
02116 

  
 24 








 and 

Kirkland & Ellis LLP 

300 North LaSalle Street 

Chicago, Illinois 60654 

Attention: Ted H. Zook, P.C. 

                  Brian C. Van Klompenberg, P.C. 

6.6 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of (a) the Company; (b) the holders of at least 75% of the Registrable Securities then outstanding; and (c) the
holders of a majority of the then outstanding shares of Series D Preferred Stock of the Company (the “Majority Series D Investors”) (provided that the consent of the Majority Series D Investors shall not be required for any
amendment or waiver if such amendment or waiver does not adversely affect the holders of Series D Preferred Stock in a manner that in the totality of circumstances is different than the effect on the holders of Series A Preferred Stock, Series B
Preferred Stock and/or Series C Preferred Stock); provided that the Company may in its sole discretion waive compliance with Section 2.12(c) (and the Company’s failure to object promptly in writing after notification of a proposed
assignment allegedly in violation of Section 2.12(c) shall be deemed to be a waiver); and provided further that any provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of any other
party. Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment,
termination, or waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of Section 4 with respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if such
waiver does so by its terms, notwithstanding the fact that certain Investors may nonetheless, by agreement with the Company, purchase securities in such transaction). The Company shall give prompt notice of any amendment or termination hereof or
waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this Section 6.6 shall be binding on all parties hereto,
regardless of whether any such party has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any
such term, condition, or provision. 
 6.7 Severability. In case any one or more of the provisions contained in this Agreement is for
any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed
and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 
 6.8 Aggregation of Stock.
All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among
themselves in any manner they deem appropriate. 

  
 25 








 6.9 Entire Agreement. This Agreement (including any Schedules hereto) constitutes the full
and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. 

6.10 Dispute Resolution. The parties hereto (a) hereby irrevocably and unconditionally submit to the jurisdiction of the Chancery
Court of the State of Delaware, and any state appellate court therefrom within the state of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, any state or federal court within the
state of Delaware), for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the
Chancery Court of the State of Delaware, and any state appellate court therefrom within the state of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, any state or federal court
within the state of Delaware), and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the
above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or
the subject matter hereof may not be enforced in or by such court. 
 6.11 WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES ITS RIGHTS
TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY
AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND
STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH
ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. 

6.12 Costs of Enforcement. If any party to this Agreement seeks to enforce its rights under this Agreement by legal proceedings, the
non-prevailing party shall pay all costs and expenses incurred by the prevailing party, including, without limitation, all reasonable attorneys’ fees. 

6.13 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement, upon
any breach or default of any other 

  
 26 








 
party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any such
breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this
Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 6.14 Acknowledgment. The Company
acknowledges that the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises which may have products or services which compete
directly or indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such enterprise has products or services
which compete with those of the Company. 
 6.15 Additional Investors. Notwithstanding anything to the contrary contained herein,
including without limitation Section 6.6, if the Company sells additional shares of Series D Preferred Stock after the date hereof pursuant to the Series D Purchase Agreement, any purchaser of such shares of Series D Preferred Stock may become
a party to this Agreement by executing and delivering a counterpart signature page to this Agreement, and thereafter shall be deemed an “Investor” for all purposes hereunder (and Schedule A hereto shall be updated accordingly). No action
or consent by the Investors shall be required for such joinder to this Agreement by such additional Investor, so long as such additional Investor has agreed in writing to be bound by all of the obligations as an “Investor” hereunder. 

6.16 Termination of Prior Agreement. Upon the effectiveness of this Agreement, the Prior Agreement shall terminate and be of no further
force or effect, and shall be superseded and replaced in its entirety by this Agreement. 
  

  
 27 








 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first written above. 
  

			
	ACACIA COMMUNICATIONS, INC.
		
	By:	 	 /s/ Murugesan Shanmugaraj

	Name:	 	 Murugesan Shanmugaraj

	Title:	 	 President and Chief Executive Officer




  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	INVESTORS:
	
	MATRIX PARTNERS VIII, L.P.
	
	By: Matrix VIII US Management Co., L.L.C., its General Partner
		
	Signature:	 	 /s/ Stan Reiss

	Name:	 	 Stan Reiss

		 	Managing Member
	
	WESTON & CO. VIII LLC, as Nominee
	
	By: Matrix Partners Management Services, L.P., Sole Member
	
	By: Matrix Partners Management Services GP, LLC, its General Partner
		
	Signature:	 	 /s/ Stan Reiss

	Name:	 	 Stan Reiss

		 	Authorized Member



  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	INVESTORS:
	
	EGAN MANAGED CAPITAL III, L.P.
		
	By:	 	EMC Partners III, L.P.
		 	its General Partner
		
	By:	 	 /s/ Michael H. Shanahan

	Name:	 	Michael H. Shanahan
		 	Managing Partner
	
	B3 PROPERTIES LLC CLASS C
		
	By:	 	Caruth Management, LLC,
		 	its Manager
		
	By:	 	  

		 	Managing Member



  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	INVESTORS:
		
	By:	 	 /s/ Gary Martin

		 	Gary Martin



  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	INVESTORS:
	
	COMMONWEALTH CAPITAL VENTURES IV L.P.
	
	By: COMMONWEALTH VENTURE (GP) PARTNERS IV L.P., its General Partner
	
	By: COMMONWEALTH VENTURE (GP) PARTNERS IV LLC, its General Partner
		
	By:	 	 /s/ Justin Perreault

	Name:	 	Justin Perreault
		 	Manager



  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	INVESTORS:
	
	SUMMIT PARTNERS VENTURE CAPITAL FUND III-A, L.P.
		
	By:	 	Summit Partners VC III, L.P.
	Its:	 	General Partner
		
	By:	 	Summit Partners VC III, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Peter Y. Chung

	Name:	 	Peter Y. Chung
	Title:	 	Member
	
	SUMMIT PARTNERS VENTURE CAPITAL FUND III-B, L.P.
		
	By:	 	Summit Partners VC III, L.P.
	Its:	 	General Partner
		
	By:	 	Summit Partners VC III, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Peter Y. Chung

	Name:	 	Peter Y. Chung
	Title:	 	Member



  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	SUMMIT INVESTORS I, LLC
		
	By:	 	Summit Investors Management, LLC
	Its:	 	Manager
		
	By:	 	Summit Partners, L.P.
	Its:	 	Manager
		
	By:	 	Summit Master Company, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Peter Y. Chung

	Name:	 	Peter Y. Chung
	Title:	 	Member
	
	SUMMIT INVESTORS I (UK), L.P.
		
	By:	 	Summit Investors Management, LLC
	Its:	 	General Partner
		
	By:	 	Summit Partners, L.P.
	Its:	 	Manager
		
	By:	 	Summit Master Company, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Peter Y. Chung

	Name:	 	Peter Y. Chung
	Title:	 	Member



  
 SIGNATURE
PAGE TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 








 
			
	INVESTORS
		
	By:	 	 /s/ Eric Swanson

	Name:	 	Eric Swanson









 SCHEDULE A 

Investors 
 Matrix Partners VIII,
LP 
 Bay Colony Corporate Center 
 1000 Winter Street,
Suite 4500 
 Waltham, MA 02451 
 Attn: Stan Reiss 

Phone: (781) 890-2244 
 Fax: (781) 890-2288 

Email: sreiss@matrixpartners.com 
 Weston & Co. VIII
LLC, as nominee 
 Bay Colony Corporate Center 
 1000
Winter Street, Suite 4500 
 Waltham, MA 02451 
 Attn: Stan
Reiss 
 Phone: (781) 890-2244 
 Fax: (781) 890-2288

 Email: sreiss@matrixpartners.com 
 Eric Swanson 

493 Baldwin Road 
 Carlisle, MA 01741 

OFS FITEL, LLC 
 2000 Northeast Expressway 

Norcross, GA 30071 
 Ruoding Li 

193 Davis Road 
 Carlisle, MA 01741 

John LoMedico 
 5 Zambom Terrace 

Andover, MA 01810 
 Robert Manlick 

c/o Acacia Communications, Inc. 
 3 Clock Tower Place 

Maynard, MA 01754 
 Gary Martin 

179C Lakeshore Road 
 Boxford, MA 01921 







 G&H Partners 

1200 Seaport Blvd. 
 Redwood City, CA 94063 

Raj Shanmugaraj 
 c/o Acacia Communications, Inc. 

3 Clock Tower Place 
 Maynard, MA 01754 

Commonwealth Capital Ventures IV L.P. 
 950 Winter Street,
Suite 4100 
 Waltham, MA 02451 
 Massachusetts Development
Finance Agency 
 Attn: James Kenney 
 160 Federal Street

 Boston, MA 02110 
 Phone: 617-330-2049; Fax: 617-330-2054

 Silicon Valley Bank 
 Attn: Treasury Department 

3003 Tasman Drive, HA 200 
 Santa Clara, CA 95054 

Telephone: 408-654-7400 
 Facsimile: 408-496-2405 

Egan Managed Capital III, L.P. 
 30 Federal Street 

Boston, MA 02110 
 B3 Properties LLC Class C 

c/o Egan Managed Capital 
 30 Federal Street 

Boston, MA 02110 
 Summit Partners Venture Capital Fund III-A,
L.P. 
 Summit Partners Venture Capital Fund III-B, L.P. 

Summit Investors I, LLC 
 Summit Investors I (UK), L.P.

 c/o Summit Partners, L.P. 
 200 Middlefield Road, Suite
200 
 Menlo Park, CA 94025